Brian Nowosielski

David Blair, CEO of LucyRx, discusses the common challenges his clients face and how his company’s innovative model can help them overcome financial hurdles.

Ashley Keller, CPhT, hosted a session at the Total Pharmacy Solutions Summit Spring 2025 exploring the services and strategies community pharmacies can employ to make their businesses thrive.

Throughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.

Using a cost-utility analysis, researchers addressed the cost-effectiveness of pneumococcal vaccine strategies for adults over the age of 64.

Micah Cost, PharmD, MS, CAE, CEO of the Pharmacy Quality Alliance, hosted the keynote session at the Total Pharmacy Solutions Summit Spring 2025 event.

In an update to the Journal of Pain Research’s formative meta-analysis on pain management in the US, researchers focused on the racial and ethnic disparities in access to pain treatment.

Expert on pain medicine, Mark Garofoli, PharmD, BCGP, CPE, CTTS, joined Drug Topics to discuss trends in the safety and efficacy of OTC pain medications and what products patients often seek at the pharmacy.

In a comprehensive review, researchers aimed to explore seasonality, environmental factors, and the genetic and epigenetic mechanisms of patients living with psoriasis vulgaris.

In a review of skin inflammation’s link to food allergen sensitivity, researchers explored how patients with atopic dermatitis may be more susceptible to the development of food allergies.

In part 3 of our interview with Jenny Markell, BA, she discussed drug advertising trends among Alzheimer’s disease drugs and how FDA suggestions are not necessarily followed.

Researchers explored various types of self-expression among pharmacists and how they were associated with experience in community pharmacy-led deprescribing.

In a conversation with David Blair, CEO of LucyRx, he discussed his company’s unique business model and how it is giving back to patients, providers, and plan sponsors alike.

Researchers conducted a study to understand how community pharmacist referrals translated to the acceptance and completion of annual wellness visits.

Jenny Markell, BA, discussed the ongoing trends in prescription drug advertising and touched on her research into the impact it has on consumers.

Researchers explored how entrustable professional activities can revolutionize workplace-based training and evolve the role of pharmacists within dermatology clinics.

With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.

Researchers wanted to understand the distribution of pneumococcal conjugate vaccine serotypes and how they have potential to impact pneumococcal disease severity and burden.

Bird flu cases total 70 US patients as more animals are infected.

Researchers conducted a comprehensive review of allergic contact dermatitis, detailing the condition’s epidemiology, pathophysiology, clinical manifestations, diagnostic approaches, and therapeutic options.

A HealthDay Harris Poll highlights the most recent feelings patients have towards vaccines amid outbreaks of vaccine-preventable illness and changes at the federal level impacting public health policy.

Researchers explored the efficacy of a targeted mailing campaign for improving pneumococcal vaccination coverage among adults 65 and over.

Jenny Markell, BA, joined us to discuss the nuances of drug promotion in the US and how specific medications are targeted to various patient populations.

Antonio Ciaccia, President of 3 Axis Advisors, led a discussion on pharmacy benefit manager reform and how the inability to pass legislation has led to increased financial hardships in community pharmacy.

Jean-Venable Goode, BSPharm, PharmD, and Jeff Goad, PharmD, MPH, presented on the most notable vaccine updates from the past year and how they impact pharmacy practice.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Drug Topics to discuss which indications patients typically gravitate toward for the use of GLP-1 medications.

Lauren Angelo, PharmD, MBA, discussed current vaccination sentiments across the country and how misinformation has contributed to declining rates among US patients.

According to data science expert Don Roosan, PharmD, PhD, the capabilities of ChatGPT are just the beginning of what the future of artificial intelligence may look like in pharmacy practice.

Lucas Berenbrok, PharmD, MS, discussed pharmacy deserts and how closures around the US have the potential to impact public health.

Haley Pals, PharmD, BCPP, and Thomas Franko, PharmD, discussed the best approaches in the use of buprenorphine for treating patients with SUD.

With the rise of large-language models like ChatGPT, pharmacists must know the potential challenges they may encounter when using these new technologies.